- Home
- RKT vs TARS Comparison
RKT vs TARS Comparison
Compare RKT & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKT
- TARS
- Stock Information
- Founded
- RKT 1985
- TARS 2016
- Country
- RKT United States
- TARS United States
- Employees
- RKT N/A
- TARS N/A
- Industry
- RKT Finance: Consumer Services
- TARS Medicinal Chemicals and Botanical Products
- Sector
- RKT Finance
- TARS Health Care
- Exchange
- RKT Nasdaq
- TARS Nasdaq
- Market Cap
- RKT 1.9B
- TARS 2.0B
- IPO Year
- RKT 2020
- TARS 2020
- Fundamental
- Price
- RKT $13.25
- TARS $47.84
- Analyst Decision
- RKT Sell
- TARS Strong Buy
- Analyst Count
- RKT 13
- TARS 6
- Target Price
- RKT $13.81
- TARS $56.00
- AVG Volume (30 Days)
- RKT 3.0M
- TARS 449.4K
- Earning Date
- RKT 02-27-2025
- TARS 02-25-2025
- Dividend Yield
- RKT N/A
- TARS N/A
- EPS Growth
- RKT N/A
- TARS N/A
- EPS
- RKT N/A
- TARS N/A
- Revenue
- RKT $4,304,653,000.00
- TARS $129,621,000.00
- Revenue This Year
- RKT $13.36
- TARS $921.89
- Revenue Next Year
- RKT $31.76
- TARS $85.83
- P/E Ratio
- RKT N/A
- TARS N/A
- Revenue Growth
- RKT 13.77
- TARS 801.96
- 52 Week Low
- RKT $10.06
- TARS $20.08
- 52 Week High
- RKT $21.38
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- RKT 58.16
- TARS 39.21
- Support Level
- RKT $12.60
- TARS $49.86
- Resistance Level
- RKT $13.45
- TARS $53.22
- Average True Range (ATR)
- RKT 0.51
- TARS 2.44
- MACD
- RKT 0.04
- TARS -0.56
- Stochastic Oscillator
- RKT 86.03
- TARS 7.09
About RKT Rocket Companies Inc.
Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and is now the largest mortgage originator in the U.S. as well as the servicer for more than 2 million loans.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.